CTRI/2007/091/000042已完成2 期
Safety and efficacy comparison of two NN1250 formulations and insulin glargine all in combination with metformin in insulin naive subjects with type 2 diabetes, measured by HbA1c after 16 weeks of treatment
ovo Nordisk AS0 个研究点目标入组 116 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 116
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Insulin naive type 2 subjects for at least 3 months
- •2. Treatment with a stable dosing of maximally tolerated dose or at least half maximally allowed dose of one or two OADs for at least 2 months
- •3. HbA1c 7.0-11.0% (both inclusive)
- •4. Body mass index (BMI) 25-42 kg/m2 (both inclusive)
排除标准
- •1. Metformin contraindication according to local practice
- •2. Treatment with thiazolidinedione (TZD) within the last 3 months prior to screening
- •3. Any systemic treatment with products which in the investigator's opinion could interfere with glucose or lipid metabolism (e.g. systemic corticosteroids) 3 months prior to randomisation
- •4. Any disease or condition which according to the investigator would interfere with the trial
研究者
相似试验
进行中（未招募）
不适用
A trial comparing efficacy and safety of NN1250 and insulin glargine in subjects with type 2 diabetestype 2 diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2009-010662-28-IEovo Nordisk A/S450
进行中（未招募）
不适用
A trial comparing efficacy and safety of NN1250 and insulin glargine in subjects with type 2 diabetesEUCTR2009-010662-28-GBovo Nordisk A/S450
进行中（未招募）
1 期
A trial comparing efficacy and safety of NN1250 andinsulin glargine in subjects with type 2 diabetestype 2 diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2009-010662-28-FRovo Nordisk A/S
已完成
3 期
Comparison of NN1250 with sitagliptin in subjects with type 2 diabetes never treated with insuliCTRI/2010/091/000024ovo Nordisk AS446
进行中（未招募）
1 期
A trial comparing efficacy and safety of NN5401 withinsulin glargine, both in combination with oralantidiabetic drugs in subjects with type 2 diabetestype 2 diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-005767-34-FRovo Nordisk A/S